Tessier-Lavigne Marc

Former Board of Director at REGN; Director at DNLI; EVP, RESEARCH DRUG DISCOVERY at GENENTECH INC

Sold, on record
$92.3M
Dollars the filings state
Form 4 sales
25
Latest Nov 23, 2022
Form 144 notices
1
Proposed sales
Companies
3
Filed as an executive or holder

Companies

  • REGNREGENERON PHARMACEUTICALS, INC.Former Board of Director
  • DNLIDenali Therapeutics Inc.Director
  • GENENTECH INCEVP, RESEARCH DRUG DISCOVERY

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale DNLIPlan not stated
    Mar 23, 2022 2022

    Sold 20,000 shares at $33.83 ($677k)

    Tessier-Lavigne Marc, Director

    Sold 1% of holdings ($69.2M position)2M shares left0.3x usual sizeFiling

  2. 2 Form 4 sale DNLIPlan not stated
    Jul 25, 2022 +124 days

    Sold 20,000 shares at $35.61 ($712k)

    Tessier-Lavigne Marc, Director

    Sold 1% of holdings ($70.2M position)2M shares left0.4x usual sizeFiling

  3. 3 Form 4 sale DNLIPlan not stated
    Aug 23, 2022 +29 days

    Sold 20,000 shares at $31.61 ($632k)

    Tessier-Lavigne Marc, Director

    Sold 1% of holdings ($61.7M position)1.9M shares left0.4x usual sizeFiling

  4. 4 Form 4 sale DNLIPlan not stated
    Sep 28, 2022 +36 days

    Sold 20,000 shares at $30.82 ($616k)

    Tessier-Lavigne Marc, Director

    Sold 1% of holdings ($59.5M position)1.9M shares left0.4x usual sizeFiling

  5. 5 Form 4 sale REGNUnusual
    Oct 3, 2022 +5 days

    Sold 10,838 shares at $702.24 ($7.6M)

    Tessier-Lavigne Marc, Director

    Sold 82.7% of holdings ($9.2M position)2,269 shares left1.1x usual sizeFiling

  6. 6 Form 4 sale DNLIPlan not stated
    Nov 2, 2022 +30 days

    Sold 20,000 shares at $30.27 ($605k)

    Tessier-Lavigne Marc, Director

    Sold 1% of holdings ($57.8M position)1.9M shares left0.6x usual sizeFiling

  7. 7 Form 4 sale DNLIPlan not stated
    Nov 23, 2022 +21 days

    Sold 20,000 shares at $30.48 ($610k)

    Tessier-Lavigne Marc, Director

    Sold 1.1% of holdings ($57.6M position)1.9M shares left1x usual sizeFiling

  8. 8 Form 144 notice REGNNotice
    Oct 3, 2023 +314 days

    Filed to sell 16,362 shares ($13.2M)

    Tessier-Lavigne Marc, Former Board of Director

    No 10b5-1 plan1.8x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (26)

Form 144 notices and Form 4 sales by Tessier-Lavigne Marc
Source
Oct 3, 2023Oct 3, 2023REGNFormer Board of DirectorForm 144 notice16,362$13.2MNoticeSEC
Nov 23, 2022Nov 28, 2022DNLIDirectorForm 4 sale20,000$610k1.1%Plan not statedSEC
Nov 2, 2022Nov 3, 2022DNLIDirectorForm 4 sale20,000$605k1.0%Plan not statedSEC
Oct 3, 2022Oct 3, 2022REGNDirectorForm 4 sale10,838$7.6M82.7%UnusualSEC
Sep 28, 2022Sep 30, 2022DNLIDirectorForm 4 sale20,000$616k1.0%Plan not statedSEC
Aug 23, 2022Aug 25, 2022DNLIDirectorForm 4 sale20,000$632k1.0%Plan not statedSEC
Jul 25, 2022Jul 27, 2022DNLIDirectorForm 4 sale20,000$712k1.0%Plan not statedSEC
Mar 23, 2022Mar 25, 2022DNLIDirectorForm 4 sale20,000$677k1.0%Plan not statedSEC
Mar 21, 2022Mar 23, 2022REGNDirectorForm 4 sale7,439$5.1M76.6%UnusualSEC
Mar 17, 2022Mar 18, 2022REGNDirectorForm 4 sale12,191$8.3M84.3%UnusualSEC
Dec 30, 2021Dec 30, 2021DNLIDirectorForm 4 sale63,131$2.8M44.5%UnusualSEC
Dec 9, 2021Dec 10, 2021REGNDirectorForm 4 sale3,784$2.5M64.6%UnusualSEC
Sep 13, 2021Sep 15, 2021REGNDirectorForm 4 sale12,750$8.2M86.0%UnusualSEC
Jun 7, 2021Jun 8, 2021DNLIDirectorForm 4 sale94,378$6.6M3.6%Plan not statedSEC
May 24, 2021May 24, 2021DNLIDirectorForm 4 sale46,763$2.8M1.8%Plan not statedSEC
May 3, 2021May 5, 2021DNLIDirectorForm 4 sale3,237$195k0.1%Plan not statedSEC
Apr 1, 2021Apr 5, 2021DNLIDirectorForm 4 sale50,000$2.8M1.9%Plan not statedSEC
Mar 1, 2021Mar 3, 2021DNLIDirectorForm 4 sale100,000$6.6M3.6%Plan not statedSEC
Jun 16, 2020Jun 18, 2020DNLIDirectorForm 4 sale400,000$10.4M12.7%Plan not statedSEC
May 6, 2020May 8, 2020REGNDirectorForm 4 sale15,000$8.5M89.1%UnusualSEC
Feb 13, 2020Feb 14, 2020REGNDirectorForm 4 sale14,279$5.7M88.6%UnusualSEC
Aug 5, 2015Aug 5, 2015REGNDirectorForm 4 sale5,000$3M80.8%UnusualSEC
Feb 26, 2015Feb 27, 2015REGNDirectorForm 4 sale3,000$1.3M71.7%UnusualSEC
Aug 27, 2014Aug 27, 2014REGNDirectorForm 4 sale3,000$1.1M71.7%UnusualSEC
May 6, 2013May 8, 2013REGNDirectorForm 4 sale13,334$3.5M100.0%UnusualSEC
Jul 16, 2008Jul 18, 2008GENENTECH INCEVP, RESEARCH DRUG DISCOVERYForm 4 sale18,750$1.5M94.2%UnusualSEC